A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT06311682 · RECRUITING
Trial details
- NCT number
- NCT06311682
- Sponsor
- LEO Pharma
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2026-10-20
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.